Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
7.83
-0.29 (-3.57%)
At close: Sep 12, 2025, 4:00 PM EDT
7.98
+0.15 (1.92%)
After-hours: Sep 12, 2025, 5:05 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202005 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2005 - 2019
Gyre Pharmaceuticals
105.76M
Log In
Log In
Log In
Log In
Upgrade
Gyre Pharmaceuticals Growth
-6.78%
Log In
Log In
Log In
Log In
Upgrade
Protease Engineering
-
Log In
Log In
Log In
Log In
Upgrade
Protease Engineering Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202005 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2005 - 2019
China
105.76M
Log In
Log In
Log In
Log In
Upgrade
China Growth
-6.78%
Log In
Log In
Log In
Log In
Upgrade
United States
-
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-
Log In
Log In
Log In
Log In
Upgrade